| GTO ID | GTC2675 |
| Trial ID | NCT04863066 |
| Disease | HIV-1 Infection |
| Altered gene | HIV-1 gene |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | HIV-1 CAR-T cells |
| Generation | 3rd |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Third-Generation CAR-T-cell Therapy in Individuals With HIV-1 Infection |
| Year | 2021 |
| Country | China |
| Company sponsor | Beijing 302 Hospital |
| Other ID(s) | 2020-HIV-001 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||